Consider your questions below and respond to the following:
Did the patient receive treatment that benefits his condition?
o Do I need to use the treatments and the medication they prescribe and their doctors?
o Is the treatment cost efficiency?
o The patient reevaluated for cancer and retested.
o Was the patient advised about the confidentiality act of his privacy rights?
Focus your discussion and your questions on the needs of the patient regarding their care, at least the standard of care that will be offered in this integrative model. What are some other questions you would have regarding the treatment aspect of your care? In your follow up questions, do you discern any biases for CAM? Why or why not? Clinically speaking what is the most important aspect of treatment, from your regard? How is this being met with this new model?
Use this to answer the question above.
As the consumer, some of the things that should be evaluated will be ensuring there are enough clinical officers before integrating the CAH practitioners. Through this, it will help in ensuring the clinical practice are well established. The integration of CAH practitioners is adding more health workers in the clinics since there a few workers who usually strain while in the delivery of their services of treating cancer (Sansom-Daly, U. M., 2015). Offering training to the employees of the clinics since is another thing to evaluated, as a patient in that hospital, I witnessed them lacking the best skills for dealing with cancer patients especially in the guidance and counseling sector. There will be the need for evaluating the services offered in that clinic since they sometimes lack medicines that are very crucial in the treatment of cancer. Improving on the equipment's that are used and adding more to cater for all patients in the hospital.
Offering the following.
o Did the patient receive treatment that benefits his condition?
o Do I need to use the treatments and the medication they prescribe and their doctors?
o Is the treatment cost efficiency?
o The patient reevaluated for cancer and retested.
o Was the patient advised about the confidentiality act of his privacy rights?
References
Sausen, M., Phalen, J., Adleff, V., Jones, S., Leary, R. J., Barrett, M. T. ... & Hruban, C. A. (2015). Clinical implications of genomic alterations in the tumor and circulation of pancreatic cancer patients. Nature communications.
Wiener, L., Weaver, M. S., Bell, C. J., & Sansom-Daly, U. M. (2015). Threading the cloak: palliative care education for care providers of adolescents and young adults with cancer. Clinical oncology in teenagers and young adults, 5, 1.